Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Clinical Trials of Post-Progression Therapy for mRCC

Metastatic RCC: Decision Trees for Second-Line Therapy

Choosing Post-Progression Therapy for Metastatic RCC

Defining Progression in Metastatic Kidney Cancer

Choosing Frontline Therapy for Metastatic Kidney Cancer 

Goals of Therapy for Advanced Kidney Cancer

Rapidly Evolving Paradigms for Treating Advanced RCC

The Future of Bladder Cancer Research

Bladder Cancer: Monoclonal Antibodies Under Investigation

BCG-Refractory Superficial Bladder Cancer

Bladder Cancer: Immunotherapy in the Perioperative Setting

Combination Trials in Advanced Bladder Cancer

Immunotherapy Toxicity Management in Bladder Cancer

Update on Durvalumab for Metastatic Bladder Cancer

Chemotherapy Following Immunotherapy in Bladder Cancer

Activity of Immunotherapy in the Frontline Setting

Bladder Cancer: Real-World Experience With Immunotherapy 

FDA Approval of Atezolizumab for Advanced Bladder Cancer

PD-L1 Expression in Bladder Cancer 

Prognostic Subgroups in Advanced Bladder Cancer

Urothelial Cancer

The OncLive Urology condition center page is a comprehensive resource for clinical news and expert insights on urologic cancers, including prostate cancer, bladder cancer, testicular cancer, penile cancer, and renal cell carcinoma. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

Prostate Cancer

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 